Terms: = Liver cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Clinical Outcome
4 results:
1. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract] [Full Text] [Related]
2. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC.
Giannelli G; Marinosci F; Trerotoli P; Volpe A; Quaranta M; Dentico P; Antonaci S
Int J Cancer; 2005 Nov; 117(3):506-9. PubMed ID: 15906357
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.
Zhao JG; Feng GS; Kong XQ; Li X; Li MH; Cheng YS
World J Gastroenterol; 2004 Apr; 10(8):1152-6. PubMed ID: 15069716
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma.
Han YM; Park HH; Lee JM; Kim JC; Hwang PH; Lee DK; Kim CS; Choi KC
J Vasc Interv Radiol; 1999 Oct; 10(9):1275-80. PubMed ID: 10527208
[TBL] [Abstract] [Full Text] [Related]
